KIF20A is a Prognostic Marker for Female Patients with Estrogen Receptor-Positive Breast Cancer and Receiving Tamoxifen as Adjuvant Endocrine Therapy

PURPOSE: Our aim was to verify whether KIF20A has the potential to serve as a prognostic marker for female patients with estrogen receptor (ER)-positive breast cancer (BC) and treated with tamoxifen (TAM). PATIENTS AND METHODS: Online tools were used to investigate the potential correlation between...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xuchen, Li, Sainan, Gao, Wei, Shi, Jiajie, Cheng, Meng, Mi, Yunzhe, Liu, Yueping, Sang, Meixiang, Li, Ziyi, Geng, Cuizhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455948/
https://www.ncbi.nlm.nih.gov/pubmed/37637711
http://dx.doi.org/10.2147/IJGM.S425918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455948/
https://www.ncbi.nlm.nih.gov/pubmed/37637711
http://dx.doi.org/10.2147/IJGM.S425918

Ejemplares similares